Fundamentals of Professional Nursing
Comprehensive Medication and Diagnostic Assessment for Post-Surgical Paralysis Management in a Rehab Setting
Student Name
Institutional Affiliation
Course
Instructor’s Name
Date
|
Drug Name (Trade/Generic, Dose, Route & Frequency) |
Pharmaceutical & Therapeutic Class, Expected Action |
Medical Diagnosis & How it Helps |
Side Effects & Adverse Reactions/Complications/Top Assessments |
Nursing Administration: Special Instructions & Assessment |
Client Education: Evaluation of Medication Effectiveness (e.g., Pain Scale) |
|
1. Baclofen 5mg, Oral, 4 times daily (QID) |
Muscle Relaxant, Antispastic; reduces muscle spasms (Romito et al., 2021). |
Paralysis and muscle spasticity post-T3 burst fracture; reduces muscle rigidity and spasticity (Romito et al., 2021). |
Drowsiness, weakness, headache, insomnia, nausea; monitor for increased weakness or breathing difficulties (Romito et al., 2021). |
Assess muscle tone and spasms; monitor for side effects and effectiveness |
Inform about potential drowsiness; report increased muscle weakness (Romito et al., 2021). |
|
2. Midodrine 10 mg, Oral, at 0800, 1300, and 1800 |
Vasopressor; raises blood pressure (Sheldon et al., 2021). |
Orthostatic hypotension due to paralysis; helps maintain stable blood pressure when changing positions (Sheldon et al., 2021). |
Scalp tingling, chills, urinary urgency; monitor blood pressure and heart rate |
Monitor blood pressure before and after administration, especially when changing positions (Sheldon et al., 2021). |
Educate on monitoring blood pressure and signs of hypertension (Sheldon et al., 2021). |
|
3. Sertraline 100mg, Oral, daily |
Antidepressant, SSRI; increases serotonin levels (Huddart et al., 2020). |
Potential depression; improves mood and emotional state (Huddart et al., 2020). |
Dry mouth, nausea, dizziness, insomnia; monitor for worsening depression or suicidal ideation (Huddart et al., 2020). |
Monitor mood changes, suicidal thoughts, and effectiveness of medication |
Inform about gradual effectiveness and to report any mood changes (Huddart et al., 2020). |
|
4. Hydrocodone 5/325, Oral, every 6 hours for pain |
Opioid Analgesic; reduces moderate to severe pain (Cofano & Yellon, 2022). |
Pain management post-surgery and due to paralysis; relieves pain (Cofano & Yellon, 2022). |
Constipation, nausea, dizziness, addiction risk; monitor pain level and signs of over-sedation |
Assess pain before and after administration; monitor for signs of dependency (Cofano & Yellon, 2022). |
Educate on proper use, risks of addiction, and to report ineffective pain control (Cofano & Yellon, 2022). |
|
5. Dulcolax suppository, Rectal, every 3 days |
Laxative; stimulates bowel movement (Corsetti et al., 2021). |
Bowel incontinence; facilitates bowel movements |
Abdominal cramps, diarrhea; monitor bowel movements and signs of abdominal pain (Corsetti et al., 2021). |
Ensure proper administration technique; monitor for bowel regularity and signs of bowel obstruction (Corsetti et al., 2021). |
Inform about importance of regular bowel movements and potential abdominal discomfort |
High-Risk Medication Template: Hydrocodone 5/325
· Uses: Pain management in cases of moderate to severe pain, especially post-surgical and in chronic conditions like paralysis.
· Risks: Risk of addiction, respiratory depression, constipation, nausea, and dizziness. Over-sedation and potential for overdose.
· Nursing Responsibilities: Regular monitoring of pain levels, vital signs, and signs of over-sedation or dependency. Proper dosing and timing of administration. Monitoring bowel habits due to risk of constipation.
· Patient Education: Educate about the risk of addiction, proper usage, and when to seek help for pain management. Inform about side effects and the importance of adhering to prescribed dosage.
2
LABS AND DIAGNOSTIC TESTS
1. Complete Blood Count (CBC)
· Normal Results: Ranges can vary slightly, but generally, WBC 4.5-11.0 x10^3/uL, RBC 4.7-6.1 x10^6/uL for men, Hemoglobin 13.8-17.2 g/dL for men, Hematocrit 40.7-50.3% for men, Platelets 150-450 x10^3/uL (Ware, 2020).
· Expected Abnormalities: Given Mr. Clark's pressure ulcer and potential for infection, an elevated WBC count could be expected, signifying infection or inflammation.
· Significance: An elevated WBC count would necessitate further investigation for infection and more aggressive wound care management.
2. Serum Albumin
· Normal Results: 3.4-5.4 g/dL.
· Expected Abnormalities: Lower levels of serum albumin may be observed, possibly due to his nutritional status affected by alcohol abuse and current health condition.
· Significance: Low albumin levels can indicate malnutrition and can impact wound healing, especially relevant for his pressure ulcer. This would warrant nutritional interventions (Goldfarb-Rumyantzev & Schulman, 2023).
3. Urinalysis
· Normal Results: Clear, yellow urine; pH 4.5-8; Specific gravity 1.005-1.030; Negative for protein, glucose, ketones, blood (Goldfarb-Rumyantzev & Schulman, 2023).
· Expected Abnormalities: Presence of proteins or leukocytes might be expected due to his incontinence and use of Foley catheter, indicating potential urinary tract infection (UTI).
· Significance: Abnormal results can suggest a UTI or kidney issues, requiring potential antibiotic treatment or adjustments in bladder management.
4. Blood Glucose Levels
· Normal Results: Fasting glucose: 70-99 mg/dL; Postprandial (2 hours after eating): <140 mg/dL (Bolla & Priefer, 2020).
· Expected Abnormalities: Elevated levels may be seen due to his obesity and potential stress from his current health condition.
· Significance: High blood glucose levels can impair wound healing and increase infection risk. It may require dietary adjustments or glucose management strategies.
5. Spinal Imaging (X-ray, MRI, or CT)
· Normal Results: Normally aligned vertebrae without fractures or misalignment.
· Expected Abnormalities: Post-surgical changes at the T3 level and any signs of further complications post-stabilization.
· Significance: These imaging results are crucial for assessing the status of the surgical site, ensuring the stability of the spine, and planning further rehabilitation interventions.
References
Bolla, A. S., & Priefer, R. (2020). Blood glucose monitoring-an overview of current and future non-invasive devices. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5), 739-751. https://doi.org/10.1016/j.dsx.2020.05.016
Cofano, S., & Yellon, R. (2022). Hydrocodone. In StatPearls [Internet]. StatPearls Publishing.
Corsetti, M., Landes, S., & Lange, R. (2021). Bisacodyl: A review of pharmacology and clinical evidence to guide use in clinical practice in patients with constipation. Neurogastroenterology & Motility, 33(10), e14123. https://doi.org/10.1111/nmo.14123
Goldfarb-Rumyantzev, R. S. B. A., & Schulman, R. (2023). Urinalysis and Diagnostic Tests. Clinical Handbook of Nephrology-E-Book, 60.
Huddart, R., Hicks, J. K., Ramsey, L. B., Strawn, J. R., Smith, D. M., Babilonia, M. B., ... & Klein, T. E. (2020). PharmGKB summary: sertraline pathway, pharmacokinetics. Pharmacogenetics and genomics, 30(2), 26. doi: 10.1097/FPC.0000000000000392
Romito, J. W., Turner, E. R., Rosener, J. A., Coldiron, L., Udipi, A., Nohrn, L., ... & Romito, B. T. (2021). Baclofen therapeutics, toxicity, and withdrawal: a narrative review. SAGE open medicine, 9, 20503121211022197. https://doi.org/10.1177/20503121211022197
Sheldon, R., Faris, P., Tang, A., Ayala-Paredes, F., Guzman, J., Marquez, M., ... & POST 4 investigators. (2021). Midodrine for the prevention of vasovagal syncope: a randomized clinical trial. Annals of internal medicine, 174(10), 1349-1356. https://doi.org/10.7326/M20-5415
Ware, A. D. (2020). The complete blood count and white blood cell differential. In Contemporary practice in clinical chemistry (pp. 429-444). Academic Press. https://doi.org/10.1016/B978-0-12-815499-1.00025-9